Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1530 Niflumic acidSummary: Ca2+-activated Cl- channel blocker
- B1457 Diclofenac SodiumSummary: COX inhibitor
- B1445 Flunixin MegluminTarget: COXSummary: potent cyclooxygenase inhibitor
- B1455 Tolfenamic AcidSummary: Non-steroidal anti-inflammatory drug
- B1595 Succinylcholine Chloride DihydrateSummary: Nicotinic AChR agonist
- B1449 Mefenamic AcidSummary: Anti-inflammatory agent
- B1484 LevosulpirideSummary: Antipsychotic drug
- B1483 FenoldopamTarget: D1 and D5 ReceptorsSummary: D1-like dopamine receptor partial agonist
- B1545 Brompheniramine hydrogen maleateSummary: Histamine H1 receptors antagonist
- B1460 ZaltoprofenSummary: Cyclooxygenase (COX) inhibitor